Fries S - Search Results

1

Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.

Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA. Grosser T, et al. Among authors: fries s. Circulation. 2013 Jan 22;127(3):377-85. doi: 10.1161/CIRCULATIONAHA.112.117283. Epub 2012 Dec 4. Circulation. 2013. PMID: 23212718 Free PMC article. Clinical Trial.

2

COX-2-derived prostacyclin confers atheroprotection on female mice.

Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, Fitzgerald GA. Egan KM, et al. Among authors: fries s. Science. 2004 Dec 10;306(5703):1954-7. doi: 10.1126/science.1103333. Epub 2004 Nov 18. Science. 2004. PMID: 15550624

3

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Egan KM, et al. Among authors: fries s. Circulation. 2005 Jan 25;111(3):334-42. doi: 10.1161/01.CIR.0000153386.95356.78. Epub 2005 Jan 17. Circulation. 2005. PMID: 15655126

4

COX-2-derived prostacyclin modulates vascular remodeling.

Rudic RD, Brinster D, Cheng Y, Fries S, Song WL, Austin S, Coffman TM, FitzGerald GA. Rudic RD, et al. Among authors: fries s. Circ Res. 2005 Jun 24;96(12):1240-7. doi: 10.1161/01.RES.0000170888.11669.28. Epub 2005 May 19. Circ Res. 2005. PMID: 15905461

5

The cardiovascular pharmacology of COX-2 inhibition.

Fries S, Grosser T. Fries S, et al. Hematology Am Soc Hematol Educ Program. 2005:445-51. doi: 10.1182/asheducation-2005.1.445. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304418

6

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Grosser T, Fries S, FitzGerald GA. Grosser T, et al. Among authors: fries s. J Clin Invest. 2006 Jan;116(1):4-15. doi: 10.1172/JCI27291. J Clin Invest. 2006. PMID: 16395396 Free PMC article. Review.

7

Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.

Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, DeMarco S, Pletcher MT, Wiltshire T, FitzGerald GA. Fries S, et al. Gastroenterology. 2006 Jan;130(1):55-64. doi: 10.1053/j.gastro.2005.10.002. Gastroenterology. 2006. PMID: 16401468 Clinical Trial.

8

Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.

Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, Reilly M, Lawson JA, FitzGerald GA. Song WL, et al. Among authors: fries s. J Biol Chem. 2008 Jan 11;283(2):1179-88. doi: 10.1074/jbc.M706839200. Epub 2007 Nov 8. J Biol Chem. 2008. PMID: 17993463 Free article.

9

Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.

Song WL, Paschos G, Fries S, Reilly MP, Yu Y, Rokach J, Chang CT, Patel P, Lawson JA, Fitzgerald GA. Song WL, et al. Among authors: fries s. J Biol Chem. 2009 Aug 28;284(35):23636-43. doi: 10.1074/jbc.M109.024075. Epub 2009 Jun 11. J Biol Chem. 2009. PMID: 19520854 Free PMC article.

10

Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin.

Li R, Fries S, Li X, Grosser T, Diamond SL. Li R, et al. Among authors: fries s. Clin Chem. 2013 Aug;59(8):1195-204. doi: 10.1373/clinchem.2012.198101. Epub 2013 Apr 16. Clin Chem. 2013. PMID: 23592503 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters